Aesica on Recruitment Drive at Queenborough Site
News Jan 14, 2016
This initiative follows the company’s strategic decision to relocate development and clinical manufacturing services from Nottingham to Queenborough.
Consequently, the company is looking for talented individuals to come and join the organisation in a variety of roles. An active plan is in place to recruit additional staff, over the course of the next 12 to 24 months, across formulation and analytical science, Quality Control, business development and project management disciplines.
Ian Muir, Managing Director at Aesica Pharmaceuticals commented: “We feel that the range and depth of experience and services that our Queenborough development centre will offer on site, provides present and future staff real scope for extensive and broad ranging career experience.”
All those that are interested are directed to the Aesica careers page on the further information link below or should make contact with the careers team at email@example.com
PhoreMost and Plexxikon Collaborate to Identify Novel Drug TargetsNews
PhoreMost, the UK-based biopharmaceutical company dedicated to drugging ‘undruggable’ disease targets, today announced it has signed a collaborative agreement with Plexxikon Inc., the small molecule structure-guided R&D centre of Daiichi Sankyo.READ MORE
Lonza Opens World’s Largest Dedicated Cell-and-Gene-Therapy Manufacturing Facility in TexasNews
First-of-its-kind, state-of-the-art manufacturing facility with capacity to produce treatment for thousands of patients suffering from rare genetic disorders or life-threatening diseases.READ MORE
IONTAS and IGEM Therapeutics Collaborate to Identify Novel IgE AntibodiesNews
The project will add to IGEM’s pipeline of drugs and expand upon IGEM-F, an IgE targeting ovarian and other cancers, currently in a Phase 1/2a study.READ MORE